EHF and ovarian cancer: Recent studies have demonstrated that KLF5 forms a transcriptional complex with EHF and ELF3, remodeling RAD51 transcription to enhance the homologous recombination repair (HRR) pathway in ovarian cancer cells, thereby promoting ovarian cancer progression and PARPi resistance [25].